Tag Archives: ENVA

Top Tech Stocks For 2019

Leave a reply

On Tuesday, our Under the Radar Movers newsletter suggested going long on small cap semiconductor stock Pixelworks, Inc (NASDAQ: PXLW):

“There are a couple of things going on with Pixelworks that are prompting this purchase. One of them is the steep low and subsequent reversal from the 9th (marked with an arrow on the chart). All it took for that selloff to turn into a capitulation is a brush with the 200-day moving average line, and ever since then it’s been nothing but buying. At the same time, thank to today’s high-volume surge, PXLW has broken above a major technical ceiling. While overbought in the short run, there’s still a ton of room to reclaim here after the major pullback before the August reversal.”

Our Under the Radar Movers newsletter has a more thorough discussion about Pixelworks’ technical chart and a potential long trading strategy:

Top Tech Stocks For 2019: Euro FX(P)

Advisors’ Opinion:

  • [By Evan Niu, CFA]

    In happier news, Sirius XM (NASDAQ:SIRI) finally acquired Pandora (NYSE:P). Tune in to find out what this deal will mean for shareholders, what these companies are trying to achieve by joining forces, and why some analysts and investors are skeptical.

  • [By Paul Ausick]

    Pandora Media Inc. (NYSE: P) dropped about 2.2% Friday to post a new 52-week low of $4.39 after closing at $4.49 on Thursday. The stock’s 52-week high is $13.72. Volume was about 6.1 million, about 40% below the daily average of around 11 million. The music streaming company had no specific news.

  • [By Rich Smith]

    Pandora Media (NYSE:P) stock is on a tear.

    After reporting earnings Thursday, Pandora shares soared 20% in early trading Friday. Wall Street bankers are scrambling to jump on the bandwagon, with at least two analysts so far rushing out new buy ratings on the stock, and a third doubling down, according to reports on TheFly.com.

  • [By Rick Munarriz]

    Investors don’t have Pandora (NYSE:P) to kick around anymore. Sirius XM Holdings (NASDAQ:SIRI) closed on its purchase of the streaming music pioneer on Friday. Every share of Pandora was swapped out for 1.44 shares of Sirius XM, just three days after Pandora shareholders voted overwhelmingly in favor of the corporate combination. 

  • [By Steve Symington]

    Pandora Media (NYSE:P) announced significantly better-than-expected first-quarter 2018 results on Thursday after the market closed, and shares of the music-streaming specialist are up more than 21% in Friday’s early trading in response.

Top Tech Stocks For 2019: Enova International, Inc.(ENVA)

Advisors’ Opinion:

  • [By Shane Hupp]

    Media stories about Enova International (NYSE:ENVA) have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Enova International earned a news impact score of 0.17 on Accern’s scale. Accern also assigned news headlines about the credit services provider an impact score of 47.1141156093879 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enova International (ENVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Logan Wallace]

    Shares of Enova International Inc (NYSE:ENVA) have received an average recommendation of “Buy” from the eight research firms that are presently covering the company, Marketbeat.com reports. Six equities research analysts have rated the stock with a buy recommendation and one has given a strong buy recommendation to the company. The average 1 year price target among brokers that have issued ratings on the stock in the last year is $35.80.

Top Tech Stocks For 2019: Coca-Cola Company (KO)

Advisors’ Opinion:

  • [By Paul Ausick]

    The Coca-Cola Co. (NYSE: KO) traded down 0.33% at $43.65. The stock’s 52-week range is $41.45 to $48.62. Volume was about half the daily average of around 12.1 million. The company had no specific news.

  • [By ]

    He practices what he preaches. While Berkshire Hathaway has ownership interests in about 45 companies, the lion’s share of the portfolio (nearly two-thirds) is invested in just six names. The biggest is Apple (Nasdaq: AAPL), followed by Wells Fargo (NYSE: WFC), Kraft Heinz (Nasdaq: KHC), Bank of America (NYSE: BAC), Coca-Cola (NYSE: KO), and American Express (NYSE: AXP).Buffett isn’t afraid to make colossal investments in a small handful of positions. And with few exceptions, these big bets usually work out brilliantly. Of course, we’re also talking about the most astute stock picker of all time. For those without his legendary skills, this strategy might be far less productive — possibly even dangerous.

  • [By Paul Ausick]

    The Coca-Cola Co.’s (NYSE: KO) Coca-Cola soft drink is the top-ranked brand in the world for the sixth consecutive year with consumer reach points totaling more than 5.8 billion. Here’s a list of all 17 including the consumer reach points of each. Reach points measure how many households around the world are buying a brand (penetration) and how often (consumer choice) and, Kantar Worldpanel says, provides a true representation of shopper choice.

  • [By Motley Fool Staff]

    Coca-Cola (NYSE:KO) is adding Costa coffee to its broad empire, and with the deal comes retail stores, a vending machine business, and significant production capacity for hot beverages.

  • [By Wayne Duggan]

    Pharmacist John Pemberton sold the first ever bottle of Coca-Cola as a medicine back in 1886. Pemberton initially charged 5 cents per glass for his carbonated concoction. Asa Candler purchased the Coca-Cola formula and brand in 1889 and founded The Coca-Cola Co (NYSE: KO) in 1902.

  • [By Dan Caplinger]

    Investors have gotten used to the dichotomy between Monster’s two key segments. The legacy Monster Energy drink unit, which includes all of the company’s more established brands, enjoyed a 16% rise in sales. That shows once again that Monster isn’t giving much consideration to bulking up the performance of its strategic brands segment, which includes the energy-drink brands it acquired from Coca-Cola (NYSE:KO) in their partnership arrangement. Strategic brands revenue dropped 5% during the fourth quarter compared to the year-ago period. The catch-all other revenue category saw a modest gain of $400,000 to $5.1 million in segment revenue, representing about half a percent of Monster’s overall sales.

Hot Medical Stocks To Watch For 2019

Leave a reply

&l;p&g;Most of us have had to try to confront some awkward issues with aging parents. It might be getting them to talk about the need for help at home. It could be about giving up those car keys. Hardest of all, perhaps, is the subject of end of life and advance healthcare planning. Estate planners have documents for that, but no one in healthcare is going to understand them unless families or loved ones are clear about the aging person&s;s wishes and can advocate for them.

&a;nbsp;

A document that empowers a decision maker to tell the medical providers what the elder wants are just vague enough to be capable of interpretation in several ways. For example, what is meant by &q;extraordinary measures&q; or &q;life prolonging treatment&q;, typical of words used in advance healthcare directives? Some will read them one way and others will see them differently. A talk with an aging parent can clear up vagueness but you need to know what to ask.

Not only have I had to bring up these topics with my own inlaws, I hear about a lot of friends who are in the same situation. Being Boomers, we may have aging parents still with us. If not, we are&q; the elders&q; ourselves and we need to have these discussions with our adult kids, friends or whomever we want to assign the task of being our own advocates. The good news is that we can get downloadable tools to help us.

Hot Medical Stocks To Watch For 2019: Eaton Vance Limited Duration Income Fund(EVV)

Advisors’ Opinion:

  • [By Logan Wallace]

    Eaton Vance Ltd Duration Income Fund (NYSEAMERICAN:EVV) was the recipient of a large increase in short interest in September. As of September 14th, there was short interest totalling 61,700 shares, an increase of 154.4% from the August 31st total of 24,249 shares. Currently, 0.1% of the company’s shares are short sold. Based on an average trading volume of 199,358 shares, the short-interest ratio is currently 0.3 days.

Hot Medical Stocks To Watch For 2019: Enova International, Inc.(ENVA)

Advisors’ Opinion:

  • [By Max Byerly]

    Enova International (NYSE: ENVA) and Regional Management (NYSE:RM) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

  • [By Joseph Griffin]

    Enova International (NYSE:ENVA) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Enova International, Inc. is a provider of online financial services. It offers loans to customers in the United States and in the United Kingdom, Australia and Canada. The Company’s customers include consumers who have bank accounts but use alternative financial credit services because of their limited access to more traditional consumer credit from banks, thrifts, credit card companies and other lenders. Enova International, Inc is headquartered in Chicago. “

  • [By Shane Hupp]

    Media stories about Enova International (NYSE:ENVA) have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Enova International earned a news impact score of 0.17 on Accern’s scale. Accern also assigned news headlines about the credit services provider an impact score of 47.1141156093879 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Enova International (ENVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Enova International (ENVA)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Hot Medical Stocks To Watch For 2019: AdvanSix Inc. (ASIX)

Advisors’ Opinion:

  • [By Ethan Ryder]

    GSA Capital Partners LLP reduced its holdings in AdvanSix Inc (NYSE:ASIX) by 36.7% during the 1st quarter, according to the company in its most recent disclosure with the SEC. The fund owned 24,620 shares of the company’s stock after selling 14,277 shares during the quarter. GSA Capital Partners LLP owned about 0.08% of AdvanSix worth $856,000 as of its most recent filing with the SEC.

  • [By Max Byerly]

    AdvanSix (NYSE:ASIX) Director Michael Marberry bought 1,398 shares of the stock in a transaction on Monday, May 7th. The stock was purchased at an average price of $35.74 per share, for a total transaction of $49,964.52. The purchase was disclosed in a document filed with the SEC, which can be accessed through this link.

  • [By Joseph Griffin]

    AdvanSix Inc (NYSE:ASIX) shares hit a new 52-week low during mid-day trading on Wednesday . The company traded as low as $32.23 and last traded at $32.33, with a volume of 2848 shares trading hands. The stock had previously closed at $32.70.

  • [By Logan Wallace]

    AdvanSix (NYSE:ASIX) was downgraded by stock analysts at ValuEngine from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Friday.

Hot Medical Stocks To Watch For 2019: NVIDIA Corporation(NVDA)

Advisors’ Opinion:

  • [By Beth McKenna]

    NVIDIA (NASDAQ:NVDA) reported powerful fiscal first-quarter 2019 results after the market close on Thursday. The graphics processing unit (GPU) specialist’s revenue jumped 66%, GAAP earnings per share soared 151%, and EPS adjusted for one-time factors rocketed 141%. Bottom-line results demolished Wall Street’s expectation, and the top line comfortably beat the consensus.

  • [By Beth McKenna]

    If so, here are four best-in-class stocks with solid long-term growth potential that are worth your consideration: graphics chip specialist NVIDIA (NASDAQ:NVDA), e-commerce and cloud-computing service behemoth Amazon.com (NASDAQ:AMZN), water utility giant American Water Works (NYSE:AWK), and water-technology specialist A.O. Smith (NYSE:AOS).  

  • [By Leo Sun]

    AMD likely forged that alliance with Intel to counter NVIDIA (NASDAQ:NVDA), which was aggressively expanding into notebooks with its M, MX, and GTX-series GPUs. However, Kaby Lake G’s arrival also confused many consumers, who erroneously thought it was an APU that merged an Intel CPU with an AMD GPU. That launch arguably overshadowed Ryzen Mobile’s arrival.

  • [By ]

    There are all sorts of different technologies to make it work and even different ways to get the same result. Even the companies involved are broad-based, ranging from big-tech like Alibaba Holding Group (BABA) to Intel Corporation (INTC)  , Alphabet Inc.  (GOOGL) (GOOG)  and Nvidia Corporation (NVDA)  — with Nvidia and Alphabet being holdings in Jim Cramer’s Action Alerts PLUS Charitable Trust Portfolio. There’s startups big and small, ride-sharing companies like Uber and Lyft, as well as seemingly every automaker getting involved.

  • [By Lisa Levin]

    Some of the stocks that may grab investor focus today are:

    Wall Street expects Magna International Inc. (NYSE: MGA) to report quarterly earnings at $1.7 per share on revenue of $10.11 billion before the opening bell. Magna shares gained 1.23 percent to $61.60 in after-hours trading.
    Analysts expect NVIDIA Corporation (NASDAQ: NVDA) to post quarterly earnings at $1.45 per share on revenue of $2.89 billion after the closing bell. NVIDIA shares rose 0.18 percent to $256.25 in after-hours trading.
    Synaptics, Incorporated (NASDAQ: SYNA) reported better-than-expected earnings for its third quarter, while sales missed estimates. Synaptics shares fell 7.43 percent to $43.00 in the after-hours trading session.
    After the markets close, News Corporation (NASDAQ: NWSA) is estimated to post quarterly earnings at $0.07 per share on revenue of $1.99 billion. News Corp shares gained 0.01 percent to $16.51 in after-hours trading.
    Analysts are expecting Duke Energy Corporation (NYSE: DUK) to have earned $1.14 per share on revenue of $5.78 billion in the latest quarter. Duke Energy will release earnings before the markets open. Duke Energy shares fell 0.03 percent to $77.62 in after-hours trading.
    Booking Holdings Inc (NASDAQ: BKNG) reported stronger-than-expected results for its first quarter. The company sees sales growth of 11.5-15.5 percent year over year and adjusted EBITDA in the range of $1.085 billion-$1.125 billion. Booking Holdings shares dropped 7.03 percent to $2,030.00 in the after-hours trading session.

    Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

  • [By Casey Wilson]

    The scientific community is absolutely ecstatic over this new technology.  In fact, this company just took home the highly prestigious Gold Edison Award – joining the likes of NVIDIA Corp. (Nasdaq: NVDA) and Tesla Inc. (Nasdaq: TSLA).

Hot Medical Stocks To Watch For 2019: CorVel Corp.(CRVL)

Advisors’ Opinion:

  • [By Ethan Ryder]

    CorVel Co. (NASDAQ:CRVL) Chairman V Gordon Clemons sold 2,250 shares of the company’s stock in a transaction on Thursday, June 21st. The stock was sold at an average price of $52.85, for a total transaction of $118,912.50. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

  • [By Max Byerly]

    GSA Capital Partners LLP grew its holdings in CorVel Co. (NASDAQ:CRVL) by 145.5% during the first quarter, HoldingsChannel reports. The firm owned 13,494 shares of the business services provider’s stock after acquiring an additional 7,997 shares during the period. GSA Capital Partners LLP’s holdings in CorVel were worth $682,000 at the end of the most recent reporting period.

  • [By Logan Wallace]

    AON (NYSE: AON) and CorVel (NASDAQ:CRVL) are both finance companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, institutional ownership, valuation, profitability, risk, analyst recommendations and dividends.

Hot Medical Stocks To Watch For 2019: HealthEquity, Inc.(HQY)

Advisors’ Opinion:

  • [By Brian Feroldi]

    So where am I going to invest my capital? While I’m still refining my list, here are seven stocks that I currently own that I’m strongly considering adding to:

    Hubspot (NYSE: HUBS) — A software-as-a-service provider that is pioneering the shift toward “inbound” marketing. HealthEquity (NASDAQ: HQY) — A fast-growing company focused on Health Savings Accounts that boasts three sources of recurring revenue. Axon Enterprise (NASDAQ: AAXN) — The leading provider of Taser stun guns, law enforcement body cameras, and evidence-management software. Paycom Software (NYSE: PAYC) — A founder-led payroll-processor company that is gobbling up market share. Adobe Systems (NASDAQ: ADBE) — The company’s push to the cloud is driving double-digit gains in revenue and profits. AppFolio (NASDAQ: APPF) — A software-as-a-service provider focused on servicing business owners in several niche markets.  BlackLine (NASDAQ: BL) — A software company that is attempting to bring the accounting process into the 21st century. 

    All seven of these businesses are poised to deliver double-digit organic revenue and profit growth over the next five years. That’s a prospect I find quite enticing, and I think the odds are very favorable that they’ll outperform Apple as a group from here. 

  • [By Max Byerly]

    Here are some of the news headlines that may have impacted Accern’s analysis:

    Get Healthequity alerts:

    HealthEquity Inc. (HQY) VP Darcy G. Mott Cut 10000 Shares (bharatapress.com) Investors Love This Stock?: HealthEquity, Inc. (HQY) (bitcoinpriceupdate.review) Insider Selling: Healthequity Inc (HQY) Director Sells 15,000 Shares of Stock (americanbankingnews.com) Notable ETF Inflow Detected – IJT, STMP, HQY, TREX (nasdaq.com) You Need to Watch this stock? HealthEquity, Inc. (HQY) (connectinginvestor.com)

    Several brokerages have issued reports on HQY. Barrington Research boosted their price target on shares of Healthequity to $85.00 and gave the company an “outperform” rating in a report on Tuesday, June 5th. They noted that the move was a valuation call. Oppenheimer boosted their price target on shares of Healthequity from $68.00 to $85.00 and gave the company an “outperform” rating in a report on Tuesday, June 5th. Robert W. Baird boosted their price target on shares of Healthequity from $61.00 to $77.00 and gave the company a “neutral” rating in a report on Tuesday, June 5th. SunTrust Banks boosted their price target on shares of Healthequity from $70.00 to $85.00 and gave the company a “buy” rating in a report on Tuesday, June 5th. Finally, KeyCorp boosted their price target on shares of Healthequity from $72.00 to $82.00 and gave the company an “overweight” rating in a report on Tuesday, June 5th. Three investment analysts have rated the stock with a hold rating, eight have assigned a buy rating and two have assigned a strong buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $77.00.

  • [By Sean Williams, Chuck Saletta, and Brian Feroldi]

    With this in mind, we asked three Motley Fool investors to name one healthcare stock that’s tops on their list for the month of June. These three mid-cap stocks made the cut: royalty drug company Innoviva (NASDAQ:INVA), mental illness treatment center operator Acadia Healthcare (NASDAQ:ACHC), and health savings account provider HealthEquity (NASDAQ:HQY).

  • [By Max Byerly]

    Healthequity Inc (NASDAQ:HQY) – Research analysts at Barrington Research issued their Q2 2019 EPS estimates for shares of Healthequity in a report issued on Tuesday, June 5th. Barrington Research analyst A. Paris. Jr expects that the company will post earnings per share of $0.20 for the quarter. Barrington Research currently has a “Outperform” rating and a $85.00 target price on the stock. Barrington Research also issued estimates for Healthequity’s FY2019 earnings at $0.70 EPS.

  • [By Brian Feroldi]

    For example, I used finviz in the recent past to find a dynamic growth company called HealthEquity (NASDAQ:HQY). I quickly learned that HealthEquity’s revenue and earnings have compounded at 38% and 57%, respectively, over the last five years. Those numbers convinced me to dig deeper and I soon became so excited about the company’s prospects that I purchased shares for myself right away.

  • [By Brian Feroldi]

    This backdrop has served as a fantastic tailwind for an innovative healthcare/tech company called HealthEquity (NASDAQ:HQY). The company provides employers, health plans, and individuals with tools and resources that enable them to maximize their savings and get the most out of every healthcare dollar. 

Top 10 Blue Chip Stocks To Buy Right Now

Leave a reply

Stocks couldnt shake off early losses and all three major indexes ended lower on Thursday.

Bloomberg News

The Dow Jones Industrial Average lost 210.79 points, or 1.17%, to 17830.76. The S&P 500 Index fell 19.34 points, or 0.92%, to 2075.81. The Nasdaq slid 57.85 points, or 1.19%, to 4805.29.

Blue chips were dragged down by Apple(AAPL): Just days after its disappointing earnings, billionaire Carl Icahn said he no longer has a stake in the stock.

From a data standpoint, First quarter gross domestic product grew 0.5%, below economists expectations, overshadowing an upbeat jobs report that saw unemployment fall to a four-decade low.

Stifels Lindsey Piegza writes that this could push out any interest rate hikes:

From a policy standpoint, should the U.S. economy post meaningful improvement between now and June, assuming the Feds concerns surrounding international risks are not reignited, policy makers appear well positioned to announce the second rate hike in less than two months time. Of course, following this mornings disappointing GDP report, its difficult to imagine a marked improvement in the economy over the next two months. More likely, the combination of stagnant economic conditions, a still-restrained consumer, and ongoing concerns regarding risks of contagion from developments abroad whether directly identified in the statement or not will make it increasingly difficult for the Fed to raise rates once in the remaining nine months of 2016, if at all.

Top 10 Blue Chip Stocks To Buy Right Now: WMIH Corp.(WMIH)

Advisors’ Opinion:

  • [By Max Byerly]

    News stories about WMIH (NASDAQ:WMIH) have trended somewhat positive on Friday, according to Accern Sentiment. Accern identifies positive and negative press coverage by reviewing more than twenty million blog and news sources in real-time. Accern ranks coverage of public companies on a scale of negative one to one, with scores closest to one being the most favorable. WMIH earned a coverage optimism score of 0.15 on Accern’s scale. Accern also gave press coverage about the financial services provider an impact score of 47.1981961674374 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock’s share price in the near term.

  • [By Stephan Byrd]

    Headlines about WMIH (NASDAQ:WMIH) have been trending somewhat positive this week, according to Accern Sentiment. Accern rates the sentiment of media coverage by analyzing more than 20 million news and blog sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. WMIH earned a daily sentiment score of 0.11 on Accern’s scale. Accern also gave headlines about the financial services provider an impact score of 46.2320142208496 out of 100, meaning that recent media coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern Sentiment Analysis’s analysis:

    Get Innovative Industrial Properties alerts:

    Return on Equity (ROE) under Consideration Innovative Industrial Properties, Inc. (NYSE:IIPR), Neonode Inc … (stocksnewspoint.com) Morning Miraculous Stocks: Taseko Mines Limited (NYSE:TGB), WMIH Corp. (NASDAQ:WMIH), Innovative Industrial … (journalfinance.net) Dazzling Stocks: Innovative Industrial Properties, Inc. (NYSE:IIPR), SORL Auto Parts, Inc. (NASDAQ:SORL), ReWalk … (thestreetpoint.com) Head-To-Head Contrast: Kennedy-Wilson (KW) vs. Innovative Industrial Properties (IIPR) (americanbankingnews.com) Innovative Industrial (IIPR) versus Colliers International Group (CIGI) Financial Contrast (americanbankingnews.com)

    A number of research analysts have weighed in on the company. Zacks Investment Research raised Innovative Industrial Properties from a “sell” rating to a “hold” rating in a report on Friday, March 16th. ValuEngine raised Innovative Industrial Properties from a “hold” rating to a “buy” rating in a report on Wednesday, May 2nd.

  • [By Stephan Byrd]

    Medallion Financial (NASDAQ: MFIN) and WMIH (NASDAQ:WMIH) are both small-cap finance companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, risk, earnings, institutional ownership, analyst recommendations, profitability and dividends.

Top 10 Blue Chip Stocks To Buy Right Now: Marathon Oil Corporation(MRO)

Advisors’ Opinion:

  • [By Matthew DiLallo]

    Marathon Oil (NYSE:MRO)also has cashed in on the improvement in oil prices. Shares of the U.S. oil company are up more than 80% over the past year — making it one of the best-performing oil stocks of 2018– due to the impact higher oil prices are having on its cash flow. Like EOG, Marathon Oil set its budget to run on $50 oil, which has it on pace to produce $500 million in free cash at $60 a barrel and even more at current prices.

  • [By ]

    Presto, West Texas Intermediate crude rose 3% to $71.18, the highest since December 2014, boosting shares of oil companies including Occidental (OXY) , which gained 4.8%, Marathon (MRO) , up 3.8%, and Apache (APA) , which gained 2.5%. Spot gasoline also rose 2.7% to $2.17 a gallon, boding ill for the summer driving season in the U.S. and potentially eroding any gains middle-class Americans received from the Trump tax cuts.

  • [By Matthew DiLallo]

    The company’s Powder River Basinassets also generated strong drilling results, with several wells topping 1,000 BOE/D. Finally, while the company did drill four wells in the Bakken, it has deferred completing them until later this year. That program is one to keep an eye on given the results Marathon Oil (NYSE:MRO) delivered last quarter, when it completed record-setting wells in the Three Forks and Middle Bakken formations.

  • [By Logan Wallace]

    Marathon Oil (NYSE:MRO) gapped down before the market opened on Thursday . The stock had previously closed at $22.09, but opened at $21.63. Marathon Oil shares last traded at $21.47, with a volume of 12430818 shares traded.

  • [By Matthew DiLallo]

    Marathon Oil (NYSE:MRO), likewise, said it would stick with its $2.3 billion drilling budget, which is enough money to grow oil and gas production in the U.S. by 25% to 30% versus last year. Because of that capital discipline, Marathon is on pace to produce more than $500 million in excess cash this year, and that’s assuming crude averages $60 a barrel.

  • [By Matthew DiLallo]

    Saudi Aramco’s valuation, however, isn’t the only one that would benefit from a pop in the price of crude. Many oil producers in the U.S. restructured their operations to run on $50 oil, so if the Saudi strategy is successful, these oil companies would produce a gusher of cash flow, which could fuel high-octane gains for investors. While that rise would likely lift the entire sector, Devon Energy (NYSE:DVN) and Marathon Oil (NYSE:MRO)could outperform in that scenario.

Top 10 Blue Chip Stocks To Buy Right Now: Monolithic Power Systems, Inc.(MPWR)

Advisors’ Opinion:

  • [By Logan Wallace]

    News headlines about Monolithic Power Systems (NASDAQ:MPWR) have been trending somewhat positive recently, Accern Sentiment Analysis reports. Accern identifies negative and positive news coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Monolithic Power Systems earned a coverage optimism score of 0.16 on Accern’s scale. Accern also gave news stories about the semiconductor company an impact score of 46.1278970459044 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the near future.

  • [By Shane Hupp]

    Get a free copy of the Zacks research report on Monolithic Power Systems (MPWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Joseph Griffin]

    Get a free copy of the Zacks research report on Monolithic Power Systems (MPWR)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Max Byerly]

    Shares of Monolithic Power Systems, Inc. (NASDAQ:MPWR) reached a new 52-week high and low on Wednesday after Deutsche Bank raised their price target on the stock from $130.00 to $140.00. Deutsche Bank currently has a buy rating on the stock. Monolithic Power Systems traded as low as $137.03 and last traded at $136.43, with a volume of 4470 shares trading hands. The stock had previously closed at $136.41.

Top 10 Blue Chip Stocks To Buy Right Now: Enova International, Inc.(ENVA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M
  • [By Joseph Griffin]

    Enova International (NYSE:ENVA) was downgraded by analysts at Zacks Investment Research from a strong-buy rating to a hold rating. According to Zacks, “Enova International, Inc. is a provider of online financial services. It offers loans to customers in the United States and in the United Kingdom, Australia and Canada. The Company’s customers include consumers who have bank accounts but use alternative financial credit services because of their limited access to more traditional consumer credit from banks, thrifts, credit card companies and other lenders. Enova International, Inc is headquartered in Chicago. “

  • [By Max Byerly]

    Enova International (NYSE: ENVA) and Regional Management (NYSE:RM) are both small-cap finance companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, earnings and institutional ownership.

  • [By Shane Hupp]

    Media stories about Enova International (NYSE:ENVA) have been trending somewhat positive recently, according to Accern. The research firm identifies negative and positive media coverage by analyzing more than twenty million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Enova International earned a news impact score of 0.17 on Accern’s scale. Accern also assigned news headlines about the credit services provider an impact score of 47.1141156093879 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the stock’s share price in the next few days.

Top 10 Blue Chip Stocks To Buy Right Now: Cinemark Holdings Inc(CNK)

Advisors’ Opinion:

  • [By Shane Hupp]

    Hodges Capital Management Inc. raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 2.0% during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 311,681 shares of the company’s stock after acquiring an additional 6,234 shares during the quarter. Hodges Capital Management Inc. owned approximately 0.27% of Cinemark worth $11,741,000 as of its most recent filing with the Securities & Exchange Commission.

  • [By Rich Smith]

    On balance, AMC’s offer still appears to fall significantly short of MoviePass’ as a value proposition (as did an earlier competing offer from Cinemark (NYSE:CNK) last year). So long as MoviePass remains in business, I honestly can’t see many moviegoers taking AMC up on its offer.

  • [By Shane Hupp]

    Blair William & Co. IL raised its stake in Cinemark Holdings, Inc. (NYSE:CNK) by 6.4% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 31,906 shares of the company’s stock after purchasing an additional 1,929 shares during the period. Blair William & Co. IL’s holdings in Cinemark were worth $1,202,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

  • [By Lisa Levin] Companies Reporting Before The Bell
    Anheuser-Busch InBev SA/NV (NYSE: BUD) is estimated to report quarterly earnings at $0.89 per share on revenue of $13.06 billion.
    SINA Corporation (NASDAQ: SINA) is expected to report quarterly earnings at $0.42 per share on revenue of $433.32 million.
    Weibo Corporation (NASDAQ: WB) is projected to report quarterly earnings at $0.47 per share on revenue of $342.39 million.
    Ameren Corporation (NYSE: AEE) is estimated to report quarterly earnings at $0.57 per share on revenue of $1.55 billion.
    Mylan N.V. (NASDAQ: MYL) is projected to report quarterly earnings at $0.98 per share on revenue of $2.75 billion.
    Cinemark Holdings, Inc. (NYSE: CNK) is estimated to report quarterly earnings at $1.31 per share on revenue of $1.51 billion.
    ADT Inc. (NYSE: ADT) is expected to report quarterly earnings at $0.24 per share on revenue of $1.11 billion.
    Coty Inc. (NYSE: COTY) is projected to report quarterly earnings at $0.13 per share on revenue of $2.18 billion.
    Pinnacle Entertainment, Inc. (NYSE: PNK) is estimated to report quarterly earnings at $0.31 per share on revenue of $644.94 million.
    Conduent Incorporated (NYSE: CNDT) is estimated to report quarterly earnings at $0.21 per share on revenue of $1.44 billion.
    Delphi Technologies PLC (NYSE: DLPH) is projected to report quarterly earnings at $1.16 per share on revenue of $1.25 billion.
    Office Depot, Inc. (NASDAQ: ODP) is expected to report quarterly earnings at $0.08 per share on revenue of $2.72 billion.
    Global Partners LP (NYSE: GLP) is estimated to report quarterly earnings at $0.13 per share on revenue of $2.33 billion.
    Wolverine World Wide, Inc. (NYSE: WWW) is projected to report quarterly earnings at $0.37 per share on revenue of $530.99 million.
    Performance Food Group Company (NYSE: PFGC) is expected to report quarterly earnings at $0.32 per share on revenue of $4.46 billion.
    Groupon, Inc. (NASDAQ: GRPN) is projected to report
  • [By Shane Hupp]

    Royal Bank of Canada raised its holdings in Cinemark Holdings, Inc. (NYSE:CNK) by 10.4% during the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 110,946 shares of the company’s stock after purchasing an additional 10,434 shares during the quarter. Royal Bank of Canada’s holdings in Cinemark were worth $4,179,000 as of its most recent SEC filing.

Top 10 Blue Chip Stocks To Buy Right Now: Partner Communications Company Ltd.(PTNR)

Advisors’ Opinion:

  • [By Logan Wallace]

    Deutsche Telekom (OTCMKTS: DTEGY) and Partner Communications (NASDAQ:PTNR) are both utilities companies, but which is the better investment? We will compare the two businesses based on the strength of their earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

  • [By Lisa Levin]

    Thursday afternoon, the health care shares rose 1.79 percent. Meanwhile, top gainers in the sector included Partner Communications Company Ltd. (NASDAQ: PTNR), up 8 percent, and Cellcom Israel Ltd. (NYSE: CEL) up 7 percent.

  • [By Joseph Griffin]

    Partner Communications (NASDAQ: PTNR) and Hutchison Telecommunications Hong Kong (OTCMKTS:HTHKY) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, analyst recommendations, valuation, risk, dividends and institutional ownership.

  • [By Lisa Levin]

    Thursday morning, the telecommunication services shares rose 1.06 percent. Meanwhile, top gainers in the sector included Globalstar, Inc. (NYSE: GSAT), up 5 percent, and Partner Communications Company Ltd. (NASDAQ: PTNR) up 4 percent.

  • [By Money Morning News Team]

    Partner Communications Co. Ltd. (Nasdaq: PTNR) is an Israeli-based mobile network operator, as well as an Internet and telephone provider. Founded in 1999, Partner was formerly operating under the umbrella of the French telecommunications company “Orange” until 2016.

Top 10 Blue Chip Stocks To Buy Right Now: Aerojet Rocketdyne Holdings, Inc. (AJRD)

Advisors’ Opinion:

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Aerojet Rocketdyne (AJRD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

  • [By Rich Smith]

    In fact, Boeing and Lockheed Martin look to be two-time winners, as the second largest bump in funding is going to help pay for deep space missions, and to NASA’s Orion crew vehicle and Space Launch System (SLS), which are designed to carry them. Orbital ATK (soon to be absorbed into Northrop Grumman) and Aerojet Rocketdyne (NYSE:AJRD) are other key players on the SLS project. Congress wants to pour an additional $294 million into this program, funding it with $5.1 billion next year.

  • [By Rich Smith]

    Aerojet Rocketdyne (NYSE:AJRD) stock lost 12% of its value in the two days after the company reported earnings for the first quarter of 2018 — a miss, and its third such miss in a row, according to data from Yahoo! Finance. Since that report and subsequent drop, however, Aerojet Rocketdyne has come roaring back, recovering all of its losses, and even adding a bit more.

  • [By Max Byerly]

    Get a free copy of the Zacks research report on Aerojet Rocketdyne (AJRD)

    For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Blue Chip Stocks To Buy Right Now: TCP Capital Corp.(TCPC)

Advisors’ Opinion:

  • [By Joseph Griffin]

    TCP Capital (NASDAQ:TCPC)‘s stock had its “buy” rating restated by equities research analysts at National Securities in a research report issued to clients and investors on Monday. They presently have a $17.00 price objective on the investment management company’s stock. National Securities’ price target indicates a potential upside of 17.24% from the stock’s previous close.

  • [By Joseph Griffin]

    TCP Capital (NASDAQ:TCPC) was upgraded by analysts at BidaskClub from a “sell” rating to a “hold” rating in a note issued to investors on Saturday.

Top 10 Blue Chip Stocks To Buy Right Now: Texas Instruments Incorporated(TXN)

Advisors’ Opinion:

  • [By Logan Wallace]

    Texas Instruments (NASDAQ: TXN) and AXT (NASDAQ:AXTI) are both computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, earnings, institutional ownership, profitability, valuation, dividends and risk.

  • [By Max Byerly]

    Investors bought shares of Texas Instruments Incorporated (NASDAQ:TXN) on weakness during trading hours on Friday. $154.33 million flowed into the stock on the tick-up and $120.49 million flowed out of the stock on the tick-down, for a money net flow of $33.84 million into the stock. Of all companies tracked, Texas Instruments had the 28th highest net in-flow for the day. Texas Instruments traded down ($1.50) for the day and closed at $115.74

  • [By Lisa Levin] Gainers
    Daré Bioscience, Inc. (NASDAQ: DARE) shares climbed 54.2 percent to $1.25 on news that the company entered into worldwide license agreement for Juniper Pharmaceuticals' intravaginal ring technology platform.
    Travelzoo (NASDAQ: TZOO) climbed 21.3 percent to $9.40 following strong Q1 results.
    Intrepid Potash, Inc. (NYSE: IPI) gained 16.5 percent to $4.60.
    K12 Inc. (NYSE: LRN) shares rose 11.2 percent to $15.4206 following Q3 results.
    Chicago Bridge & Iron Company N.V. (NYSE: CBI) shares rose 11 percent to $15.3289. McDermott issued a release reiterating rejection of Subsea 7's offer.
    Six Flags Entertainment Corporation (NYSE: SIX) shares gained 9.2 percent to $64.61 as the company posted a narrower-than-expected loss for its first quarter.
    Tupperware Brands Corporation (NYSE: TUP) surged 8.5 percent to $46.00 as the company posted in-line quarterly earnings.
    Carlisle Companies Incorporated (NYSE: CSL) climbed 7.5 percent to $107.22 after reporting Q1 results.
    Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 6.1 percent to $14.78. B. Riley initiated coverage on Allena Pharmaceuticals with a Buy rating.
    Texas Instruments Incorporated (NASDAQ: TXN) rose 4.6 percent to $102.90 after the company reported stronger-than-expected earnings for its first quarter on Tuesday.
    Credit Suisse Group AG (NYSE: CS) rose 4.5 percent to $17.03 following strong Q1 results.
    STMicroelectronics N.V. (NYSE: STM) rose 4.2 percent to $22.20 after reporting Q1 results.

    Check out these big penny stock gainers and losers

  • [By Ethan Ryder]

    Bank of Hawaii lessened its position in Texas Instruments (NASDAQ:TXN) by 4.7% during the first quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 31,725 shares of the semiconductor company’s stock after selling 1,555 shares during the period. Bank of Hawaii’s holdings in Texas Instruments were worth $3,296,000 at the end of the most recent reporting period.

  • [By Anders Bylund]

    Microchip veteran Texas Instruments (NASDAQ:TXN) just presented a bare-bones view of its second-quarter results. Tucked into the announcement of Chairman Rich Templeton taking back the CEO title again, the mini-report came in well above Wall Street’s expectations.

Top 10 Blue Chip Stocks To Buy Right Now: BB&T Corporation(BBT)

Advisors’ Opinion:

  • [By ]

    BB&T Bank (BBT) : “They report next week and I think the story will be a good one. I’d only buy into weakness. It’s still not down enough from it’s high.”

  • [By ]

    In the Lightning Round, Cramer was bullish on FMC Corp (FMC) , Pennsylvania Real Estate Investment Trust  (PEI) , Cisco Systems (CSCO) , HP (HPQ) , BB&T Bank (BBT) and HCA Holdings (HCA) .

  • [By Shane Hupp]

    News stories about BB&T (NYSE:BBT) have been trending somewhat positive on Friday, according to Accern Sentiment Analysis. The research firm ranks the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. BB&T earned a news sentiment score of 0.16 on Accern’s scale. Accern also assigned news articles about the insurance provider an impact score of 46.6887882598231 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the company’s share price in the near future.

  • [By Ethan Ryder]

    State Treasurer State of Michigan decreased its holdings in BB&T (NYSE:BBT) by 1.0% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 228,861 shares of the insurance provider’s stock after selling 2,400 shares during the quarter. State Treasurer State of Michigan’s holdings in BB&T were worth $11,910,000 as of its most recent SEC filing.

Top Insurance Stocks For 2018

Leave a reply

5 More Aetna-CVS Deal Details, from Aetna’s SEC Filings

Life Insurance Application Activity Rises

3 Things to Know About the Fiduciary Rule’s Little Brother

 

Marc-André Giguère will be taking over as president and chief executive officer of Munich Re, US (Life and Health) in January.

Giguère has been the executive vice president of reinsurance at Munich Re, US (Life), since July. He has also been the president of the Munich Re Health unit.

Giguère will be succeeding Michael DeKoning, who has been running the Munich Re, US (Life), since 2008.

DeKoning has decided to leave the company, Munich Re says in an announcement of the change.

(Related: United Arab Emirates Looks Like a Hot Life Market)

Munich Re did not discuss the reasons for DeKoning’s decision to leave the company. DeKoning could not immediately be reached for comment.

The U.S. Munich Re operations are part of Munich Re, a reinsurer based in Germany.

Top Insurance Stocks For 2018: ONEOK Inc.(OKE)

Advisors’ Opinion:

  • [By Lee Jackson]

    The volatile price of natural gas over the past year has weighed some on this top energy stock. ONEOK Inc. (NYSE: OKE) primarily engages in natural gas transportation, storage and natural gas and natural gas liquids (NGLs) gathering, processing and fractionation in the Bakken, Mid-Continent and Permian. The company recently closed the roll-up of its underlying master limited partnership, ONEOK Partners.

  • [By Shane Hupp]

    ONEOK (NYSE:OKE) – Analysts at US Capital Advisors raised their FY2018 EPS estimates for ONEOK in a research report issued to clients and investors on Monday, May 14th. US Capital Advisors analyst B. Followill now anticipates that the utilities provider will post earnings of $2.74 per share for the year, up from their previous forecast of $2.56. US Capital Advisors also issued estimates for ONEOK’s Q4 2018 earnings at $0.74 EPS and FY2019 earnings at $2.95 EPS.

  • [By Lee Jackson]

    The volatile price of natural gas over the past year has weighed some on this top energy stock. ONEOK Inc. (NYSE: OKE) primarily engages in natural gas transportation, storage and natural gas and NGLs gathering, processing and fractionation in the Bakken, Mid-Continent and Permian. The company recently closed the roll-up of its underlying master limited partnership, ONEOK Partners.

Top Insurance Stocks For 2018: Enova International, Inc.(ENVA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Top Insurance Stocks For 2018: iShares Core S&P 500 (IVV)

Advisors’ Opinion:

  • [By Stephan Byrd]

    Traders purchased shares of Ishares S&P 500 (NYSEARCA:IVV) on weakness during trading on Thursday. $298.50 million flowed into the stock on the tick-up and $154.33 million flowed out of the stock on the tick-down, for a money net flow of $144.17 million into the stock. Of all stocks tracked, Ishares S&P 500 had the 3rd highest net in-flow for the day. Ishares S&P 500 traded down ($0.50) for the day and closed at $274.75

  • [By Stephan Byrd]

    Doliver Capital Advisors LP increased its holdings in shares of Ishares S&P 500 (NYSEARCA:IVV) by 2.7% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 32,234 shares of the company’s stock after acquiring an additional 860 shares during the period. Ishares S&P 500 makes up about 3.7% of Doliver Capital Advisors LP’s portfolio, making the stock its 2nd largest holding. Doliver Capital Advisors LP’s holdings in Ishares S&P 500 were worth $8,554,000 at the end of the most recent quarter.

  • [By Todd Shriber, ETF Professor]

    The S&P 500 is one of the world's most widely followed equity indexes. There are over $7.8 trillion in global assets benchmarked to the index, according to ProShares data. The world's two largest ETFs, SPY and the iShares Core S&P 500 ETF (NYSE: IVV), track the S&P 500. Those ETFs have about $395 billion in combined assets under management and are the only two ETFs trading in the U.S. with over $100 billion in assets.

Top Blue Chip Stocks To Own Right Now

Leave a reply

President Trump needs a new director for his National Economic Council after Gary Cohn resigned.

There’s one candidate in the mix that may really please investors: Chris Liddell, who has served as chief financial officer for two blue chip American companies, GM (GM) and Microsoft (MSFT)

Liddell, like the former Goldman Sachs (GS) executive Cohn, has a background in crunching numbers and dealing with Wall Street.

The New York Times first reported on Saturday that Liddell was the “top contender” to replace Cohn. A senior White House official later confirmed to CNN that Liddell is a “possibility” as a replacement for Cohn. Liddell currently serves in the White House as the director of strategic initiatives, working closely with Jared Kushner.

Ivan Feinseth, director of research and chief investment officer at Tigress Financial Partners, said he did not think an ethics complaint filed against Liddell last year because of meetings he held at the White House with executives of companies that he owned stocks in would be a major issue either.

Top Blue Chip Stocks To Own Right Now: Piedmont Office Realty Trust, Inc.(PDM)

Advisors’ Opinion:

  • [By Paul Ausick]

    Piedmont Office Realty Trust Inc. (NYSE: PDM) dropped about 3.5% Tuesday to post a new 52-week low of $17.35. Shares closed at $17.98 on Monday and the stock’s 52-week high is $22.74. Volume was about 60% above the daily average of around 1.3 million shares. The company had no specific news.

Top Blue Chip Stocks To Own Right Now: Cheniere Energy Partners LP Holdings, LLC(CQH)

Advisors’ Opinion:

  • [By Ethan Ryder]

    Cheniere Energy Partners (NYSEAMERICAN:CQH) – Equities research analysts at US Capital Advisors boosted their Q2 2018 EPS estimates for shares of Cheniere Energy Partners in a research report issued to clients and investors on Monday, May 14th. US Capital Advisors analyst J. Carreker now expects that the energy company will post earnings of $0.57 per share for the quarter, up from their prior estimate of $0.54. US Capital Advisors also issued estimates for Cheniere Energy Partners’ Q3 2018 earnings at $0.57 EPS and Q4 2018 earnings at $0.57 EPS.

  • [By Reuben Gregg Brewer]

    I wouldn’t personally buy Cheniere Energy — it has a complex corporate structure that includes not just Cheniere Energy Partners, L.P. but also Cheniere Energy Partners LP Holdings LLC (NYSE: CQH),where the only asset is an ownership stake in Cheniere Energy Partners, L.P. Cheniere Energy is attempting to resolve this issue by acquiring Cheniere Energy Partners LP Holdings. Until that process is complete, however, that’s just too much corporate complexity for my taste.

  • [By Paul Ausick]

    Cheniere Energy Inc. (NYSEAMERICAN: LNG) announced Thursday morning that it is acquiring the approximately 8.1% of subsidiary Cheniere Energy Partners Holdings LLC (NYSEAMERICAN: CQH) that it does not already own in an all-stock deal valued at $28.24 per share of Cheniere Partners Holdings.

Top Blue Chip Stocks To Own Right Now: Enova International, Inc.(ENVA)

Advisors’ Opinion:

  • [By Lisa Levin] Gainers
    Genprex, Inc. (NASDAQ: GNPX) jumped 46.7 percent to $16.1331. The low-float small-cap clinical stage gene therapy company saw its stock rally nearly 150 percent from Monday through Thursday. Formal news hasn't been announced this week that would support a triple-digit percentage rally (including more than 200 percent at one point on Thursday) but the quiet period following its initial public offering will expire on May 8.
    Celyad SA (NASDAQ: CYAD) shares gained 24.7 percent to $36.17. Celyad reported the publication of THINK study case report of CYAD-01 Induced Complete Remission in relapsed/refractory AML patient in haematologica.
    DMC Global Inc. (NASDAQ: BOOM) shares jumped 23.2 percent to $39.00 after the company reported upbeat Q1 results and issued upbeat Q2 guidance.
    eHealth, Inc. (NASDAQ: EHTH) gained 21.8 percent to $19.58 as the company posted upbeat Q1 results.
    Enova International, Inc. (NYSE: ENVA) climbed 20.4 percent to $27.20 following Q1 results.
    SVB Financial Group (NASDAQ: SIVB) shares jumped 18.2 percent to $304.135 following strong quarterly results.
    Knowles Corporation (NYSE: KN) gained 13.9 percent to $12.70 as the company reported Q1 results.
    Zymeworks Inc. (NYSE: ZYME) gained 13.8 percent to $17.36.
    Cocrystal Pharma, Inc. (NASDAQ: COCP) rose 11.8 percent to $2.336 after declining 25.09 percent on Thursday.
    ImmunoGen, Inc. (NASDAQ: IMGN) shares surged 11.7 percent to $11.75 after the company announced 'successful completion of interim analysis' for FORWARD I Phase 3 mirvetuximab soravtansine trial.
    Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX) gained 9.5 percent to $12.70.
    Expedia Group, Inc. (NASDAQ: EXPE) shares rose 8.5 percent to $115.3801 after the company reported stronger-than-expected earnings for its first quarter on Thursday.
    Sprint Corporation (NYSE: S) shares rose 8.3 percent to $6.50. The stock moved higher after a Reuters report suggested ongoing merger talks with T-M

Top Blue Chip Stocks To Own Right Now: Insys Therapeutics, Inc.(INSY)

Advisors’ Opinion:

  • [By Keith Speights]

    In October 2017, I predicted that Insys Therapeutics (NASDAQ:INSY) could be the biggest comeback story of 2018.For a while, it looked like I was on the right track. Insys stock soared in the fourth quarter of 2017. By early January, it was one of the hottest marijuana stocks on the market. Then the momentum evaporated.

  • [By ]

    Abbvie Inc. (ABBV) , for example, is generally just a pharmaceutical stock. However, the company also marketed Marinol, an FDA-approved synthetic cannabinoid meant to help nausea and vomiting in cancer and AIDS patients. INSYS Therapeutics, Inc. (INSY) is a pharmaceutical company that got approval from the U.S. Drug Enforcement Administration (DEA) for a synthetic cannabis – despite having donated to anti-marijuana advocacy groups in the past.

  • [By Keith Speights]

    Some people picture rows of cannabis plants growing in a greenhouse when they think of marijuana stocks. While that’s an appropriate image to have in mind for many marijuana stocks, it’s a different story for others. 22nd Century Group (NYSEMKT:XXII) and Insys Pharmaceuticals (NASDAQ:INSY) are good examples.

  • [By Casey Wilson]

    Others, like cannabis biotech firm Insys Therapeutics Inc. (Nasdaq: INSY), are direct plays in marijuana businesses that offer investors the opportunity for incredibly fast gains.

  • [By Sean Williams]

    Yet in spite of this momentum, drug developer Insys Therapeutics (NASDAQ:INSY) has been an absolute train wreck. Insys offers a broad spectrum of therapies in its product portfolio and pipeline, but it gets its association with “marijuana stocks” through its Food and Drug Administration (FDA) approval of Syndros, a liquid dronabinol solution — i.e., a synthetic form of tetrahydrocannabinol (THC), the psychoactive component of the cannabis plant — designed to treat chemotherapy-induced nausea and vomiting, as well as anorexia associated with AIDS. It also has other cannabidiol-based products in development in its pipeline.

Top Blue Chip Stocks To Own Right Now: Archer-Daniels-Midland Company(ADM)

Advisors’ Opinion:

  • [By Lee Jackson]

    This is a very solid play for rocky markets and is offering a very reasonable entry point. Archer Daniels Midland Co. (NYSE: ADM) is a large agricultural services company with almost $90 billion in sales. It is in the business of converting agricultural harvest such as corn, wheat, soybeans and other products into basic ingredients for both consumer and industrial product manufacturers. Its main business lines are focused on oilseed processing, corn processing and agricultural services.

  • [By Maxx Chatsko]

    China imported 55 million gallons of American ethanol from November 2017 to the end of February 2018. It could be just the beginning. That would be great news for Archer Daniels Midland (NYSE:ADM), Green Plains (NASDAQ:GPRE), and Valero Energy (NYSE:VLO) — the three largest publicly traded ethanol producers in the United States.

Top Blue Chip Stocks To Own Right Now: Hertz Global Holdings Inc(HTZ)

Advisors’ Opinion:

  • [By Dan Caplinger]

    The stock market dealt with continued volatility on Tuesday, with investors uncertain how to react to a mix of earnings and geopolitical news. Throughout most of the day, market participants were trying to predict whether the Trump administration would move forward with its plans to withdraw the U.S. from the nuclear deal with Iran, and major benchmarks stayed in a relatively tight range with a downward bias during the morning and early afternoon. After the expected announcement, the Dow fell to a triple-digit loss late in the afternoon, but it recovered by the end of the session. Adding to the gloominess was bad news regarding some key individual stocks. DISH Network (NASDAQ:DISH), Gogo (NASDAQ:GOGO), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Lisa Levin]

    Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 17 percent to $18.505 after the company reported a wider-than-expected loss for its first quarter.

  • [By Dan Caplinger]

    Wall Street had another good session on Tuesday, with favorable earnings reports from some of the nation’s most successful technology companies helping to lift major benchmarks by 1% or more. Investors haven’t forgotten about some of the potential pitfalls that could derail the recovery, including both geopolitical and macroeconomic concerns. Yet traders seem to want to see the market test its all-time highs before deciding whether the correction could turn into a full-fledged bear market reversal. Some individual stocks, however, missed out on the good times. GoPro (NASDAQ:GPRO), Apellis Pharmaceuticals (NASDAQ:APLS), and Hertz Global Holdings (NYSE:HTZ) were among the worst performers on the day. Here’s why they did so poorly.

  • [By Lisa Levin]

    Shares of Hertz Global Holdings, Inc. (NYSE: HTZ) were down 11 percent to $19.77 after the company reported a wider-than-expected loss for its first quarter.

  • [By Paul Ausick]

    After markets closed on Monday, rental car company Hertz Global Holdings Inc. (NYSE: HTZ) and real-estate firm Zillow Group Inc. (NASDAQ: Z) reported quarterly results. Before markets opened Tuesday morning Discovery Inc. (NASDAQ: DISCA) and Dish Network Corp. (NASDAQ: DISH) also released earnings reports. Here’s a quick look at the reports and the reactions to them.

  • [By Max Byerly]

    These are some of the news articles that may have impacted Accern’s rankings:

    Get Hertz Global alerts:

    Hertz Global Holdings, Inc (HTZ) CFO Thomas C. Kennedy Buys 15,000 Shares (americanbankingnews.com) Northcoast Research Weighs in on Hertz Global Holdings, Inc’s Q2 2018 Earnings (HTZ) (americanbankingnews.com) Hertz Global Target of Unusually High Options Trading (HTZ) (americanbankingnews.com) Edited Transcript of HTZ earnings conference call or presentation 8-May-18 12:00pm GMT (finance.yahoo.com) Hertz Sweeps 2018 FlyerTalk Awards (finance.yahoo.com)

    Several equities research analysts have issued reports on HTZ shares. Zacks Investment Research upgraded Hertz Global from a “sell” rating to a “hold” rating in a research report on Wednesday, January 17th. Macquarie upgraded Hertz Global from a “neutral” rating to an “outperform” rating in a research report on Thursday, January 18th. Goldman Sachs dropped their target price on Hertz Global from $15.00 to $13.00 and set a “sell” rating on the stock in a research report on Thursday, February 15th. Finally, ValuEngine downgraded Hertz Global from a “hold” rating to a “sell” rating in a research report on Thursday, February 15th. Three investment analysts have rated the stock with a sell rating, four have issued a hold rating and four have assigned a buy rating to the company’s stock. The stock currently has an average rating of “Hold” and an average price target of $15.71.